https://www.selleckchem.com/products/cc-90001.html
The present study showed that the prescription of TXA would reduce the amount of hematoma expansion in traumatic intracerebral hemorrhage, and that medication can be introduced to reduce morbidity and complications. The present study showed that the prescription of TXA would reduce the amount of hematoma expansion in traumatic intracerebral hemorrhage, and that medication can be introduced to reduce morbidity and complications. To demonstrate the microsurgical procedures, and to evaluate the feasibility of living models of experimental
Like
Comment
Share
